We are live on
!
Find out more
CCM
Cadence Capital Management Portfolio holdings
AUM
$415M
1-Year Est. Return
11.01%
This Fund
S&P 500
This Quarter
Est. Return
-2.82%
1 Year Est. Return
-11.01%
3 Year Est. Return
+0.72%
5 Year Est. Return
+39.08%
10 Year Est. Return
–
AUM
$415M
AUM Growth
-$275M
(-40%)
Cap. Flow
-$256M
Cap. Flow
% of AUM
-61.73%
Top 10 Holdings %
Top 10 Hldgs %
38.46%
Holding
421
New
30
Increased
6
Reduced
240
Closed
144
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
MPLX
MPLX
|
+$1.61M |
| 2 |
PSXP
PHILLIPS 66 PARTNERS LP
PSXP
|
+$1.43M |
| 3 |
Plains All American Pipeline
PAA
|
+$1.42M |
| 4 |
VIVO
Meridian Bioscience Inc
VIVO
|
+$641K |
| 5 |
ECOM
CHANNELADVISOR CORPORATION
ECOM
|
+$573K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Castle Biosciences
CSTL
|
+$2.4M |
| 2 |
Century Communities
CCS
|
+$2.23M |
| 3 |
MasterCraft Boat Holdings
MCFT
|
+$2.18M |
| 4 |
CareCloud
CCLD
|
+$2.16M |
| 5 |
Fulgent Genetics
FLGT
|
+$2.15M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 45.53% |
| 2 | Healthcare | 9.95% |
| 3 | Consumer Staples | 8.81% |
| 4 | Industrials | 8.59% |
| 5 | Technology | 7.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
KeyCorp
KEY
$24.8B
| $256K | 0.06% |
21,481
-5,612
| -21% | -$68.4K |
|
252
Travere Therapeutics
TVTX
$5.23B
| $256K | 0.06% |
+13,880
| New | +$270K |
|
253
John B. Sanfilippo & Son
JBSS
$939M
| $255K | 0.06% |
3,382
-11,312
| -77% | -$943K |
|
|
PARA
254
DELISTED
Paramount Global Class B
PARA
| $252K | 0.06% |
8,989
-1,820
| -17% | -$48.8K |
|
|
SMED
255
DELISTED
Sharps Compliance Corp
SMED
| $252K | 0.06% |
40,184
-131,571
| -77% | -$957K |
|
256
Snap-on
SNA
$21B
| $250K | 0.06% |
1,702
-435
| -20% | -$63.2K |
|
257
Cincinnati Financial
CINF
$27.7B
| $247K | 0.06% |
3,174
-782
| -20% | -$60.6K |
|
258
Regions Financial
RF
$26.3B
| $244K | 0.06% |
21,186
-5,715
| -21% | -$63.8K |
|
259
Citizens Financial Group
CFG
$30.6B
| $242K | 0.06% |
9,554
-2,579
| -21% | -$65.4K |
|
260
Principal Financial Group
PFG
$23.4B
| $238K | 0.06% |
5,908
-1,504
| -20% | -$64.1K |
|
261
Watsco Inc
WSO
$14.9B
| $238K | 0.06% |
+1,021
| New | +$230K |
|
262
Dorian LPG
LPG
$1.88B
| $237K | 0.06% |
29,585
-96,530
| -77% | -$800K |
|
263
Entergy
ETR
$53.6B
| $236K | 0.06% |
4,782
-978
| -17% | -$48.4K |
|
264
Sturm, Ruger & Co
RGR
$612M
| $234K | 0.06% |
+3,824
| New | +$282K |
|
|
CTRA
265
DELISTED
Coterra Energy
CTRA
| $228K | 0.06% |
13,109
-2,991
| -19% | -$55.9K |
|
266
Electromed
ELMD
$327M
| $228K | 0.06% |
21,875
-70,841
| -76% | -$1.02M |
|
267
Transmedics
TMDX
$2.46B
| $221K | 0.05% |
+16,024
| New | +$275K |
|
268
Fennec Pharmaceuticals
FENC
$358M
| $215K | 0.05% |
35,536
-118,020
| -77% | -$832K |
|
|
AGEN
269
Agenus
AGEN
$230M
| $212K | 0.05% |
2,700
-8,959
| -77% | -$697K |
|
|
CEMI
270
DELISTED
Chembio diagnostics, Inc.
CEMI
| $201K | 0.05% |
41,293
-136,738
| -77% | -$648K |
|
271
Compañía de Minas Buenaventura
BVN
$8.15B
| $197K | 0.05% |
16,112
+2,637
| +20% | +$31.6K |
|
272
Huntington Bancshares
HBAN
$37B
| $189K | 0.05% |
20,594
-5,285
| -20% | -$49.2K |
|
273
Puma Biotechnology
PBYI
$401M
| $171K | 0.04% |
16,927
-54,252
| -76% | -$552K |
|
|
ICAD
274
DELISTED
iCAD Inc
ICAD
| $162K | 0.04% |
18,376
-59,199
| -76% | -$584K |
|
275
Arbutus Biopharma
ABUS
$855M
| $159K | 0.04% |
+50,736
| New | +$154K |
|
Similar funds
MGAI
FA
LWS
VCP
AIM
F
CPF
IA
Cadence Capital Management's Q3 2020 Portfolio in Review
As of Q3 2020, Cadence Capital Management held 421 positions worth $415M, down 40% from $689M the previous quarter. Its ten largest holdings account for 38% of the portfolio.
Cadence Capital Management withdrew a net $256M in Q3 2020, closing 144 positions and reducing 240 holdings. Its most notable exit was MasterCraft Boat Holdings, an estimated $2.18M position sold in full.
By sector, the portfolio is most concentrated in Energy at 46% of assets, up from 33% a quarter earlier, followed by Healthcare and Consumer Staples.
Against the trend, Cadence Capital Management opened a new position in Meridian Bioscience Inc worth $560K.
- Cadence Capital Management's largest Q3 2020 buy was Meridian Bioscience Inc: 33,000 shares worth $560K.
- Cadence Capital Management added most to MPLX in Q3 2020, an estimated $1.61M increase.
- Cadence Capital Management's biggest Q3 2020 reduction was Castle Biosciences, cutting an estimated $2.4M.
- Cadence Capital Management fully exited MasterCraft Boat Holdings in Q3 2020, selling an estimated $2.18M.
- Cadence Capital Management's ten largest holdings make up 38% of its $415M portfolio in Q3 2020.
- Cadence Capital Management opened 30 new positions and closed 144 in Q3 2020.
- Cadence Capital Management's portfolio value fell 40% quarter-over-quarter to $415M.
Based on Cadence Capital Management's 13F filing for Q3 2020, filed 16 Oct 2020.